| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.18▲ | 1.17▲ | 1.17▲ | 1.16▲ | 1.19▲ |
| MA10 | 1.16▲ | 1.16▲ | 1.16▲ | 1.18▲ | 1.23▼ |
| MA20 | 1.17▲ | 1.16▲ | 1.16▲ | 1.20▼ | 1.17▲ |
| MA50 | 1.17▲ | 1.20▼ | 1.21▼ | 1.24▼ | 1.21▼ |
| MA100 | 1.21▼ | 1.21▼ | 1.23▼ | 1.16▲ | 3.04▼ |
| MA200 | 1.23▼ | 1.23▼ | 1.21▼ | 1.19▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.007▲ | 0.007▲ | -0.005▼ | 0.010▲ |
| RSI | 57.867▲ | 55.915▲ | 54.935▲ | 48.620▼ | 48.740▼ |
| STOCH | 83.333▲ | 63.333 | 53.333 | 20.406 | 37.903 |
| WILL %R | 0.000▲ | -35.000 | -35.000 | -66.000 | -60.811 |
| CCI | 162.922▲ | 107.610▲ | 118.107▲ | -33.421 | -19.026 |
|
Monday, November 10, 2025 02:00 AM
LeuRS is the same validated target underlying epetraborole (in development for NTM lung disease), ganfeborole (in development for TB), and tavaborole, an FDA-approved antifungal.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/11/25 | 1.15 | 1.195 | 1.13 | 1.195 | 99,269 |
| 10/11/25 | 1.16 | 1.26 | 1.14 | 1.18 | 550,469 |
| 07/11/25 | 1.12 | 1.1501 | 1.11 | 1.14 | 32,121 |
| 06/11/25 | 1.14 | 1.17 | 1.1135 | 1.12 | 49,122 |
| 05/11/25 | 1.14 | 1.17 | 1.112 | 1.1406 | 34,527 |
| 04/11/25 | 1.14 | 1.18 | 1.13 | 1.14 | 47,936 |
| 03/11/25 | 1.24 | 1.24 | 1.12 | 1.15 | 92,793 |
| 31/10/25 | 1.23 | 1.23 | 1.19 | 1.23 | 18,248 |
| 30/10/25 | 1.28 | 1.28 | 1.21 | 1.24 | 75,922 |
| 29/10/25 | 1.30 | 1.30 | 1.23 | 1.30 | 105,880 |
|
|
||||
|
|
||||
|
|